Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2004
Mixed-membership models of scientific publicationsElena Erosheva, Stephen Fienberg, John Lafferty
Journal of Medicinal Chemistry|December 6, 2017
The Design and Development of a Potent and Selective Novel Diprolyl Derivative That Binds to the N-Domain of Angiotensin-I Converting EnzymeStephen Fienberg, Gyles E Cozier, K Ravi Acharya, et al.
The FEBS Journal|January 7, 2025
Molecular basis of human angiotensin-1 converting enzyme inhibition by a series of diprolyl-derived compoundsKyle S Gregory, Gyles E Cozier, Stephen Fienberg, et al.
ACS Infectious Diseases|September 23, 2020
Structural Basis for Inhibitor Potency and Selectivity of Plasmodium falciparum Phosphatidylinositol 4-Kinase InhibitorsStephen Fienberg, Charles J Eyermann, Lauren B Arendse, et al.
Journal of Medicinal Chemistry|May 16, 2025
Medicinal Chemistry Progression of Sapanisertib, the Anticancer and Dual Plasmodium Phosphatidylinositol 4-Kinase Beta and cGMP-Dependent Protein Kinase Inhibitor, for MalariaSamuel Gachuhi, Stephanie Kamunya, Stephen Fienberg, et al.
ACS Infectious Diseases|December 15, 2020
New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of Plasmodium Phosphatidylinositol-4-kinase and cGMP-Dependent Protein KinasePeter Mubanga Cheuka, Luyanda Centani, Lauren B Arendse, et al.
Journal of Medicinal Chemistry|May 2, 2022
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis ActivityPreshendren Govender, Rudolf Müller, Kawaljit Singh, et al.
European Journal of Medicinal Chemistry|April 17, 2026
Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitorsLutete Peguy Khonde, Nashied Peton, Keabetswe Masike, et al.
Journal of Medicinal Chemistry|October 7, 2025
Optimization of 2,8-Diaryl-1,5-naphthyridines as Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo EfficacyGodwin A Dziwornu, Donald Seanego, Stephen Fienberg, et al.
ACS Infectious Diseases|November 3, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in Mycobacterium tuberculosisVinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg, et al.
Pageof 2